Philippe Amouyal

Philippe Amouyal, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lexicon Pharmaceuticals, Inc., Cava Group, Inc. and WW International, Inc. Between 4 January 2016 and 22 June 2026, the trades on record add up to 12 filings.

The open-market record is one-sided, with 2 purchases worth €494k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants and 5 option exercises.

The latest filing, published on 24 June 2026, reports a share grant in Cava Group, Inc. The clock since the last published purchase (21 November 2023) now reads 1,062 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.